MUZASTOTUG
UNII 4L1XJF3HGL

Substance Identification & Data

This profile provides standardized clinical and technical data for Muzastotug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4L1XJF3HGL.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2750031-18-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4L1XJF3HGL

CAS Registry Number

2750031-18-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MUZASTOTUG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C179276

National Cancer Institute reference terminology for clinical and research data.

INN ID

12573

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Muzastotug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

IMMUNOGLOBULIN G1- KAPPA, ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE ASSOCIATED PROTEIN 4, CTLA-4, CD152)), MONOCLONAL ANTIBODY WITH CLEAVABLE PRODOMAIN; GAMMA1 HEAVY CHAIN (1-446) (VH (HOMO SAPIENS IGHV3-7*01 (77.8%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT (9.7.9) (26-34.52-58.97-105)) (1-116) -HOMO SAPIENS IGHG1*01 (100%), G1M17,1 CH1 K120, D12, L14 (CH1 K120 (213) (117-214), HINGE 1-15 (215-229), CH2 (230-339), CH3 D12 (355), L14 (357) (340-444), CHS (445-446)) (117-446)), (219-256')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-256') (CLEAVABLE PRODOMAIN (1'-41') FUSED TO V-KAPPA (HOMO SAPIENS IGKV1-13*02 (85.3%) -IGKJ1*01 (100%), CDR-IMGT (7.3.9) (68-74.92-94.131-139)) (42'-149') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (195), V101 (233) (150'-256')); DIMER (225-225'':228-228'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA

IMMUNOGLOBULIN G1, ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4) (HUMAN MONOCLONAL ADG126 .GAMMA.1-CHAIN), DISULFIDE WITH PRODOMAIN PEPTIDE (SYNTHETIC MASKING MOIETY AND PROTEASE-CLEAVABLE MOIETY) FUSION PROTEIN WITH HUMAN MONOCLONAL ADG126 .KAPPA.-CHAIN, DIMER

MUZASTOTUG

MUZASTOTUG (IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE ASSOCIATED PROTEIN 4, CTLA-4, CD152)), HUMANIZED MONOCLONAL ANTIBODY WITH CLEAVABLE PRODOMAIN)

MUZASTOTUG [INN]

MUZASTOTUG [WHO-DD]